Project UpdateJul 31, 2026, 09:21 AM
SciSparc Subsidiary's Quantum Platform Achieves Workflow Milestone
AI Summary
SciSparc Ltd. announced that its subsidiary, NeuroThera Labs Inc., achieved a significant technological milestone with its quantum sampling workflow platform. The platform successfully demonstrated a complete end-to-end hybrid quantum-classical workflow for clinical data analytics, capable of processing real-world clinical data and generating interpretable insights. This development, advanced through CliniQuantum Ltd. (54.01% owned by NeuroThera), confirms the platform's ability to address complex biomedical datasets using quantum-inspired methodologies.
Key Highlights
- NeuroThera Labs' quantum platform demonstrated a complete end-to-end hybrid quantum-classical workflow.
- The platform processes real-world clinical data for advanced analytics.
- It integrates secure data ingestion, quantum-enabled processing, and interpretable insights.
- The workflow was executed within a quantum simulation environment.
- Future plans include expanding dataset scale and optimizing quantum algorithms.
- NeuroThera Labs holds 54.01% in CliniQuantum Ltd., which develops the platform.
Price Impact
More from SPRC